Company intelligence / Profile preview

JW Theriac Pharmaceutical

Boston, Massachusetts, United Stateskedglobal.com ↗
Ownership
Private
Development stage
Other
01

Overview

JW Theriac Pharmaceutical serves as the US-based research subsidiary of South Korea’s JW Pharmaceutical. It focuses on global open innovation and expanding an innovative new drug pipeline by leveraging proprietary platforms such as “JWELRY” and “CLOVER.” The company specializes in oncology, immunology, regenerative medicine, metabolic disease research, and collaborates with target-oriented biotech companies worldwide. Its current programs include small molecule inhibitors targeting key pathways like Wnt/β-catenin and STAT proteins; several candidates are advancing toward first-in-human studies but remain preclinical as of now.[3][4][8]

Therapeutic areas
OncologyMetabolic DisordersImmunologyOther
Modalities
Small molecules[8]Biologics[9]Cell therapies (including immune cell therapies)[6][9]New modalities (unspecified)[9]
Industry
Biotech
02

Drug pipeline

4 assets

WE

Preclinical

3 more assets in the full pipeline.

Request access →
03

Partnerships

Engaged in global open innovation partnerships including collaborations with ARCH Venture Partners’ ATS program,[9], plus ongoing search for joint research partners among leading biotech companies worldwide.

Beyond the preview

Go deeper on JW Theriac Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JW Theriac Pharmaceutical.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call